| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.2M | $2.9M | $3.9M |
| YoY Revenue Growth % | +11.8% | -25.7% | — |
| Gross Profit | $2.1M | $1.9M | — |
| Gross Margin % | 65.3% | 64.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$113.6M | -$177.0M | -$180.4M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$105.9M | -$128.6M | -$199.4M |
| EBITDA (Normalized) | -$112.6M | -$174.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$89.2M | -$162.1M | -$150.5M |
| Capital Expenditures (CapEx) | $1.2M | $2.9M | — |
| Free Cash Flow (FCF) | -$90.4M | -$165.0M | -$150.5M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -36.9% | -45.0% | — |
| Cash & Short-Term Equivalents | $173.3M | $41.0M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $416.1M | $268.6M | — |